Lesson plan

HL23V

HL23V was reputedly a type C RNA tumor virus first isolated in 1975 from cultured human acute myelogenous leukaemia peripheral blood leukocytes in the laboratory of Robert Gallo, which would have been the first cancer-causing retrovirus isolated from human sera. It was later shown to be a laboratory contaminant of three monkey viruses. The journal Nature, which had published the original research, later retracted the article. Investigative journalist John Crewdson, writing in 2003, described how Gallo pretended mysterious laboratory accidents such as the unplugging of a laboratory freezer to excuse his failure to share samples of "HL23V" to researchers. As "HL23V" would have been the first human retrovirus discovered, bringing attention to Gallo and thus scientific prizes, observers noted that "23" was the number of Robert Gallo's birthday. Later in 1986, Max Essex of Harvard would announce the "discovery" of "HTLV-IV" in Senegalese women, supposedly a type C relative of HIV (then called HTLV-III) thought to be HIV-2. This similarly was determined to be a contaminant.

Back to article

Article summary

HL23V was reputedly a type C RNA tumor virus first isolated in 1975 from cultured human acute myelogenous leukaemia peripheral blood leukocytes in the laboratory of Robert Gallo, which would have been the first cancer-causing retrovirus isolated from human sera. It was later shown to be a laboratory contaminant of three monkey viruses. The journal Nature, which had published the original research, later retracted the article. Investigative journalist John Crewdson, writing in 2003, described how Gallo pretended mysterious laboratory accidents such as the unplugging of a laboratory freezer to excuse his failure to share samples of "HL23V" to researchers. As "HL23V" would have been the first human retrovirus discovered, bringing attention to Gallo and thus scientific prizes, observers noted that "23" was the number of Robert Gallo's birthday. Later in 1986, Max Essex of Harvard would announce the "discovery" of "HTLV-IV" in Senegalese women, supposedly a type C relative of HIV (then called HTLV-III) thought to be HIV-2. This similarly was determined to be a contaminant.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.